Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?

MLA

Turgeon, Michael K., et al. “Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?” Annals of Surgical Oncology, vol. 28, no. 1, Jan. 2021, pp. 97–105. EBSCOhost, https://doi.org/10.1245/s10434-020-08714-0.

APA

Turgeon, M. K., Gamboa, A. C., Rupji, M., Lee, R. M., Switchenko, J. M., El-Rayes, B. F., Russell, M. C., Cardona, K., Kooby, D. A., Staley, C. A., Maithel, S. K., & Shah, M. M. (2021). Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer? Annals of Surgical Oncology, 28(1), 97–105. https://doi.org/10.1245/s10434-020-08714-0

Chicago

Turgeon, Michael K, Adriana C Gamboa, Manali Rupji, Rachel M Lee, Jeffrey M Switchenko, Bassel F El-Rayes, Maria C Russell, et al. 2021. “Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?” Annals of Surgical Oncology 28 (1): 97–105. doi:10.1245/s10434-020-08714-0.